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Background: Endovascular aneurysm repair (EVAR) is not generally recommended for patients with hostile neck
anatomy. This study analyzed the clinical implications of various clinical features of proximal aortic neck anatomy.
Methods: Prospectively collected data from 258 EVAR patients using modular devices were analyzed. Patients were
classified as having favorable neck anatomy (FNA) or hostile neck anatomy (HNA). HNA was defined as any or all of
length of <10 mm, angle of >60°, diameter of >28 mm, >50% circumferential thrombus, >50% calcified neck, and
reverse taper. Univariate, multivariate, and Kaplan-Meier analyses were used to compare early and late clinical outcomes.
Results: FNAwas present in 37% andHNAwas present in 63%. Clinical and demographic characteristics were comparable.
Technical success was 99%. Mean follow-up was 22 months (range, 1-78 months). Perioperative complication rates were
3% for FNA vs 16% for HNA (P .0027). Perioperative deaths were 0% for FNA and 3% for HNA (P .2997). Proximal
type I early endoleaks (intraoperative) occurred in 9% of FNA vs 22% for HNA (P  .0202). Intraoperative proximal
aortic cuffs were used to seal endoleaks in 9% of FNA vs 22% of HNA (P  .0093). At late follow-up, abdominal aortic
aneurysm expansion was noted in 6% of FNA vs 7% of HNA (P  .8509). Rates of freedom from late type I endoleaks at
1, 2, 3, and 4 years were 97%, 97%, 97%, and 90% for FNA vs 89%, 89%, 89%, and 89% for HNA (P  .1224); rates for
late interventions were 95%, 90%, 90%, and 90% for FNA vs 95%, 93%, 91%, and 85% forHNA (P .6902). Graft patency
at 1, 2, and 3 years was 99%, 99%, and 99% for FNA vs 97%, 92%, and 90% for HNA (P .0925). The survival rates were
93%, 84%, 76%, and 76% for FNA vs 88%, 82%, 74%, and 66% for HNA (P  .2631). Reverse taper was a significant
predictor for early type I endoleak (odds ratio [OR], 5.25, P < .0001), reverse taper (OR, 5.95; P < .0001) and neck
length (OR, 4.15; P  .0146) were for aortic cuff use; circumferential thrombus (OR, 2.44; P  .0448), and neck angle
(OR, 3.38; P  .009) were for perioperative complications.
Conclusions: Patients withHNA can be treated with EVAR, but with higher rates of early (intraoperative) type I endoleak
and intervention. The midterm outcomes are similar to FNA. (J Vasc Surg 2011;54:13-21.)
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PThe introduction of endovascular aneurysm repair
(EVAR) in 1991 revolutionized the treatment of infrarenal
abdominal aortic aneurysms (AAAs). To undergo success-
ful EVAR, the patient needs a suitable aortic and iliac
anatomy.1
The aortic neck is vital for maintaining the seal of the
stent graft, therefore hostile neck anatomy (HNA) is asso-
ciated with perioperative and late type I endoleaks.2-10
Stent grafts have strict anatomic criteria in the instructions
for use (IFU) in regard to neck anatomy that need to be
met for “indicated use” to avoid endoleaks; however, a
significant number of stent grafts are presently being placed
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doi:10.1016/j.jvs.2010.12.010n aortic necks that do not meet IFU requirements in
atients who are deemed high-risk for open repair. A por-
ion of those patients are now being treated with fenes-
rated and branched endovascular grafts, but this is only
ffered at certain referral centers throughout the country.11
Several studies have compared different aspects of aor-
ic neck morphology as a predictor of outcome after EVAR,
ncluding neck length and angle.4-10 However, there are
ultiple aspects of the aortic neck that influence the ability
f the stent graft to form a seal with the aortic wall,
ncluding neck length, neck angle, neck diameter, mural
hrombus, neck calcification, and reverse taper of the neck.
o better determine which patients should be considered
or fenestrated or branch grafts and which patients should
ndergo classic EVAR, it is important to “weigh” all as-
ects of the neck morphology for a risk assessment. To our
nowledge, only a few studies have examined most aspects
f neck morphology as a predictor of early and late out-
ome after EVAR.12-14 Therefore, the purpose of this study
s to analyze the clinical implications of various clinical
eatures of proximal aortic neck anatomy.
ATIENTS AND METHODS
This study includes 258 of 601 patients who under-
ent EVAR at our institution, using a variety of Food and
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July 201114 AbuRahma et alDrug Administration approved modular devices, during a
recent 8-year period. These included AneuRx (Medtronic
Corporation, Santa Rosa, Calif), Excluder (W. L. Gore and
Assoc, Flagstaff, Ariz), Zenith (Cook Corp, Indianapolis,
Ind), and Talent (Medtronic Corp). The study only ana-
lyzed patients whose procedures were done by three of our
full-time academic faculty (A.F.A., P.A.S., and S.M.H.) and
excluded patients operated on by nonacademic physicians
because we have no control over their follow-up. Also
excluded were patients who lacked preoperative infrarenal
aortic neck measurements due to lack of good-quality
computed tomography (CT) scanning and EVAR patients
for ruptured AAAs. The study protocol was approved by the
Institutional Review Board of West Virginia University/
Charleston Area Medical Center.
Prospectively collected data were supplemented with a
retrospective review of medical records and radiologic im-
ages. The preoperative workup of these patients included
color duplex ultrasound (DUS) imaging, CT angiography
(CTA), and arteriography using a marked pigtail catheter
to select patients for endovascular therapy. The demo-
graphic and clinical characteristic profiles and six aortic
neck anatomic features—including aortic neck length, an-
gle, diameter, calcification, thrombus-lined neck, and re-
verse taper—were recorded. Intraoperative data and 30-day
postoperative adverse events were also analyzed.
Device selection was based on physician preference. All
procedures were performed in an independent Circulatory
Dynamic Laboratory under epidural or general anesthesia
using conventional fluoroscopy (General Electric Medical,
Milwaukee, Wisc). Every effort was made to deploy the
endovascular device flush with the level of the lowest renal
artery. All patients were encouraged to participate in our
postoperative surveillance protocol, which included CTA
or color DUS imaging, or both, and plain abdominal
radiography at 1, 6, and 12 months, and then every 12
Table I. Hostile neck features
Variable
No. (%)
Median (range)
Patients, No. 238
Neck features, mean 1
Hostile neck features 1 (0-5)
Hostile neck features/patient
0 89 (37.4)
1 81 (34.0)
2 49 (20.6)
3 11 (4.6)
4 7 (2.9)
5 1 (0.4)
Hostile neck features
Neck angle 60° 46 (19.3)
Neck length 10 mm 20 (8.4)
Diameter 28 mm 19 (8.0)
Calcium 50% 16 (6.8)
Thrombus circumference 50% 93 (39.1)
Reverse taper 51 (22)months thereafter. cCT scanning protocol. Standard CT follow-up pro-
ocol with and without intravenous contrast material was
ollowed, which required CT section thickness of 3 mm.
he proximal aortic neck diameter was recorded in the
inor access from adventitia to adventitia, just below the
owest renal artery. Another measurement was also made at
5 mm below the lowest renal artery, or at the distal end
f the aortic neck in patients with a short neck (15 mm).
he infrarenal aortic neck length was measured on CTA as
he distance between the lowest renal artery and the point
f the initial aneurysm dilatation or where the infrarenal
ortic diameter increased to 3 mm of the proximal neck
iameter. The aneurysmal sac size was defined as the max-
mum transverse diameter and was also measured from
dventitia to adventitia (the outer diameter). The aortic
eck angle was also calculated. This angle was measured
etween the aortic neck and the longitudinal axis of the
neurysm, as seen on preoperative arteriography. Details of
hese measurements, specifically the neck anatomy, were
eceived separately without the knowledge of the early and
ate clinical outcome of these patients.
The CT scans were reviewed by a board-certified vas-
ular surgeon or a vascular interventionalist, or both, who
as not the operating surgeon on these patients.
Definitions and end points. Patients were catego-
ized as having favorable neck anatomy (FNA) or HNA.
NA was defined as having one or more of six neck
eatures: neck length of 10 mm, angle of 60°, a diam-
ter of 28 mm, 50% circumferential proximal neck
hrombus (2 mm thick), 50% calcified proximal neck,
nd reverse taper. Reverse taper was defined as gradual neck
ilatation of 2 mm within the first 10 mm after the most
able II. Demographics and clinical characteristics by
eck anatomy
ariablea
FNA HNA
P(n  89) (n  149)
ale 67 (76) 118 (80) .5166
ge, years 74.2 (48-91) 74.3 (48-91) .9453
ypertension 73 (82) 126 (85) .6083
OPD 27 (30) 54 (36) .3523
urrent tobacco use 21 (24) 32 (21) .7038
revious tobacco use 43 (48) 75 (50) .7629
ongestive heart failure 10 (11) 19 (13) .7294
oronary artery disease 58 (65) 86 (58) .2553
ome oxygen use 9 (10) 5 (3) .0321
iabetes mellitus 24 (27) 35 (23) .5479
hronic renal disease 24 (27) 29 (19) .1782
yperlipidemia 55 (62) 86 (58) .5354
ollow-up, months 22.9 (1-75.4) 22.3 (0.1-78.1) .8176
evice type
Excluder 48 (53) 80 (54) .6869
Zenith 19 (21) 35 (23)
AneuRx 21 (24) 29 (19)
Talent 1 (1) 5 (3)
OPD, Chronic obstructive pulmonary disease; FNA, favorable neck anat-
my; HNA, hostile neck anatomy.
Data are presented as number (%) or mean (range).audal renal artery.12-16 For patients with an aortic diame-
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Volume 54, Number 1 AbuRahma et al 15ter of 28 mm, particularly for the Zenith or Talent
devices, who were treated based on the IFU with a device
designed for a neck diameter 28 mm, an additional
hostile neck feature should be present to consider the
patient to have HNA.
Pretreatment images were used to measure AAA stabil-
Table III. Abdominal aortic aneurysm characteristics by n
Variablea
FNA (n  89)
Mean (range)
AAA size, cm
Mean pre-op 5.79 (4.2 to 9.1)
Mean post-opb 5.16 (2.3 to 9.1)
[Post-op – pre-op] 0.62 (3.8 to 1.8)
Neck size, mm 23.3 (15.4 to 28)
No. (%)
AAA sac
Expansion 5 (6)
Stable/regressed 78 (94)
AAA, Abdominal aortic aneurysm; FNA, favorable neck anatomy; HNA, h
aAt last follow-up visit.
Table IV. Intraoperative and hospital variables by neck
anatomy
Variable
FNA (n  89) HNA (n  149)
PMean (range) Mean (range)
Fluoroscopy time,
minutes
23.19 (8-70) 27.2 (8-81) .0268
Estimated blood loss,
mL 259.9 (0-1200) 321 (0-2500) .1027
Transfusion amount, U 0.66 (0-6) 0.86 (0-8) .3371
Contrast used, mL 126 (30-260) 141.6 (45-355) .0622
Length of stay, days 3.95 (1-19) 4.84 (1-43) .1119
Table V. Perioperative complications by neck anatomya
Complication
FNA HNA
P
(n  89) (n  149)
No. (%) No. (%)
Myocardial infarction 3 (3) 1 (1) .1485
Iliac rupture 0 (0) 0 (0)
Thrombosis
Graft limb/ALI 0 (0) 10 (7) .0148
Deep vein 0 (0) 0 (0)
Peripheral embolization 0 (0) 1 (1) .99
Hematoma/bleeding 0 (0) 3 (2) .2947
Wound infection 0 (0) 6 (4) .0865
Sepsis 0 (0) 1 (1) .99
Colon ischemia 1 (1) 1 (1) .99
Acute renal failure 0 (0) 4 (3) .2998
Paralysis 0 (0) 2 (1) .5298
Perioperative death 0 (0) 4 (3) .2997
Any complications 3 (3) 24 (16) .0027
ALI, Acute limb ischemia; FNA, favorable neck anatomy; HNA, hostile
neck anatomy.
aAt least 1 complication.ity or shrinkage, as recommended by the Ad Hoc Commit- pee of the Standardized Reporting Practice in Vascular
urgery.15 Significant AAA sac expansion was defined as
5 mm increase of the sac size, and significant shrinkage
as defined as a decrease of 5 mm.
Endograft migration was determined by measuring the
istance from the lowest renal artery and the most cephalad
ortion of the stent graft, as seen on CTA images. Signifi-
ant migration was defined as displacement of 10 mm
rom the predischarge study or any displacement requiring
econdary intervention.
Endoleak was determined using CT, based on extrava-
ation of contrast between the prosthesis and the aneurysm
all, or by color DUS imaging where the flow and spectral
ignals were outside the prosthesis, or both. If the CT and
US results differed, contrast arteriography was done to
onfirm the endoleak. Early endoleak was defined as a leak
etected intraoperatively or 30 days of the procedure,
nd a late endoleak was defined as a leak observed30 days
natomy
HNA (n  149)
PMean (range)
6.13 (3.8 to 9.9) .0067
5.49 (3.0 to 10.6) .0587
0.63 (4.5 to 2.3) .9178
25.3 (16 to 32) .0001
No. (%)
9 (7) .8509
126 (93)
neck anatomy.
able VI. Endoleak and intervention by neck anatomy
ndoleak/intervention
FNA
(n  89)
HNA
(n  149)
PNo (%) No (%)
arly type I 8 (9) 34 (23) .0202
Intraoperative 8 (9) 33 (22)
30-days 0 (0) 1 (1)
arly type II 11 (12) 18 (12)
arly type IV 4 (4) 2 (1)
ll early endoleaks 23 (26) 54 (36) .0971
arly type I Rx
W/aortic cuff (intra-op) 8 (9) 33 (22) .0093
Late type I 7 (8) 15 (11)a .9218
Late type II 9 (11) 13 (10)
Late type III 0 1 (1)
All late endoleak 16 (19) 29 (22) .6763
Early intervention 8 (9) 41 (28) .0006
Late intervention 5 (6) 10 (7) .7177
NA, Favorable neck anatomy; HNA, hostile neck anatomy.
Two patients in this HNA group had late migrations that were treated with
ortic cuff extensions.eck aostoperatively.
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July 201116 AbuRahma et alThe primary end points for analysis for this study in-
cluded early (30 days postoperatively) outcome, specifically
the incidence of early proximal aortic endoleak (type I), use
of a proximal aortic neck extension or cuff to seal the
proximal endoleak, other secondary interventions, techni-
cal success, and surgical conversion. Secondary early out-
come included operative blood loss, transfusion require-
ment, volume of contrast used during implantation, stent
graft patency, other endoleaks (distal types I, II, III, and
IV), and other perioperative morbidity or mortality. Late
clinical outcomes included type I endoleak, other types of
endoleak, stent graft patency, aortic sac expansion, conver-
sion to open repair, stent graft migration, aneurysm rup-
ture, secondary interventions, and aneurysm-related mor-
tality.
Statistical methods. The data analysis was performed
using SAS 9.1 software (SAS Institute, Cary, NC). Basic
descriptive statistics, such as means and standard deviations
for continuous variables and proportions and frequencies
for categoric variables, were used to analyze the data.
Comparisons between the groups were performed using
contingency table analysis with a 2 or Fisher exact text
(categoric variables) and t tests (continuous variables) to
determine statistically significant differences. A multivariate
logistic regression analysis was used to try to predict which
neck features were associated with early/late endoleak,
early/late intervention, and perioperative complications.
The Kaplan-Meier method was used to estimate survival
distributions (survival, freedom from late endoleak, free-
dom from late intervention, sac expansion, and EVAR
Fig 1. Freedom from late type 1 endoleaks in patients w
(FNA).patency) for the groups. The test statistic for comparison aetween these two survival distributions was based on the
og-rank test. An  level of 0.05 was used to determine
tatistical significance.
ESULTS
This study includes 258 patients who underwent
VAR using modular devices: 135 Excluder, 65 AneuRx,
1 Zenith, and 7 Talent devices. Early and late clinical
utcomes for 20 patients were not analyzed due to the lack
f one or more of the six neck features. The mean follow-up
as 22 months (range, 1-78 months). FNA was present in
7% of patients and HNA in 63%. The technical success was
9%. The Zenith grafts in two patients failed to be deployed
hrough the iliac arteries. One patient underwent an open
epair and the other refused further treatment. Both failures
ere secondary to extensive tortuous, small, calcified iliac
rteries. Table I summarizes the various HNA features in
his series. The HNA group included 46 angulated necks,
0 short necks, 19 dilated necks, 16 calcified necks, 93
hrombus-lined necks, and 51 reverse tapered necks. The
9 patients with dilated neck (28 mm) included 15 with
he Cook Zenith device, 2 had Talent devices, and 2 had
ore Excluder devices. All patients had additional hostile
eck features.
As noted in Table II, the FNA and HNA patients had
omparable clinical and demographic characteristics. Table
II summarizes the AAA characteristics according to neck
natomy. The mean preoperative AAA size and the mean
eck size were significantly larger for HNA (P .0067 and
 .0001). Table IV summarizes the intraoperative vari-
stile neck anatomy (HNA) and favorable neck anatomyith hobles according to neck anatomy. The mean fluoroscopic
p
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Volume 54, Number 1 AbuRahma et al 17time was significantly longer for the HNA group (P 
.0268).
Table V summarizes the 30-day perioperative compli-
cations according to neck anatomy. The perioperative com-
plication rate was 3% for FNA vs 16% for HNA (P .0027).
Fig 2. Freedom from late intervention patients with hos
Fig 3. Freedom from sac expansion patients with hostiPerioperatively, no FNA patients (0%) died, but four HNA Aatients (3%) died (P  .2997): three deaths were second-
ry to myocardial infarction and one died of multisystem
ailure. The rate of graft limb thrombosis or acute limb
schemia was higher for the HNA group (P  .0148).
hese stent grafts included five Gore Excluder, one
ck anatomy (HNA) and favorable neck anatomy (FNA).
k anatomy (HNA) and favorable neck anatomy (FNA).neuRx, and six Zenith Cook devices.
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July 201118 AbuRahma et alThere were 93 patients with 50% circumferential
proximal neck thrombus; of these, 45 had circumferential
thrombus as the only hostile neck feature, and 16 had a
calcified neck (4 of these had calcified neck as the only
hostile neck feature). If the patients with 50% circumfer-
ential thrombus or50% calcified neck as the only features
were excluded, 100 patients remained with a hostile neck
feature and 138 patients with favorable neck features. In
this subset analysis, there were significantly higher rates in
hostile neck vs favorable neck for graft limb thrombosis (9%
vs 1%, P  .0021), acute renal failure (4% vs 0%, P 
.0301), perioperative death (4% vs 0%, P  .0306), and
overall complication rate (18% vs 6.5%, P  .0027).
Table VI summarizes the rates of endoleak and inter-
vention according to neck anatomy. Proximal type I early
intraoperative endoleak occurred in 9% of FNA vs 23%
(22% intraoperatively and 1% at 30 days) for HNA (P 
.0202). Intraoperative proximal aortic cuff extensions were
used to seal endoleaks in 8 patients (9%) with FNA vs 33 of
34 patients (22%) with HNA (P  .0093). Intraoperative
proximal type I endoleaks required 27 of these 34 patients
to undergo proximal aortic cuff insertion and 6 others
needed insertion of an aortic cuff and a Palmaz (Cordis,
Miami Lakes, Fla) stent. The remaining patient with HNA
was treated with an aortic cuff extension, which decreased
the endoleak, and it eventually sealed six months later.
Overall, 41 patients needed aortic cuffs to seal early type I
endoleaks (intraoperative), and 32 of these were for Gore
Excluder (25% of patients with Gore Excluder devices), in
contrast to 9 in patients with non-Gore devices (8% of the
non-Gore devices, P  .0006).
Early intervention was also statistically significantly
higher in patients with HNA (28%) vs FNA (9%, P 
.0006). As noted earlier, the early interventions in FNA
patients were proximal aortic extension cuffs, in contrast to
33 of 41 HNA patients who had proximal aortic cuffs with
Table VII. Univariate and multivariate logistic regression
Regression analyses
Early type I endo
OR 95% CI
Univariate
Neck angle 1.91 0.89-4.1
Neck length 4.59 1.76-11.93
Diameter 0.93 0.26-3.34
Calcified neck 5.5 1.93-15-65
Circumferential thrombus 1.07 0.54-2.12
Reverse taper 5.97 2.87-12.42
Multivariate
Neck angle 1.27 0.51-3.14
Neck length 2.97 0.94-9.41
Diameter 0.56 0.13-2.37
Calcified neck 2.44 0.71-8.34
Circumferential thrombus 0.96 0.45-2.08
Reverse taper 5.25 2.4-11.46
CI, Confidence interval; OR, odds ratio.
aStatistically significant.
bNo diameter data are included because there were no late type I endoleaksor without Palmaz stents, and 8 other patients had other incillary procedures, including 5 thrombectomies of the
rafts and 3 patients had thrombectomies with femoral-to-
emoral crossover bypass grafts. The incidence of early type
I endoleak was similar for both FNA and HNA patients.
As indicated earlier, in a subset analysis excluding pa-
ients who had only 50% circumferential neck thrombus
nd 50% calcified neck as the only hostile neck features,
here was a significantly higher incidence of early intraop-
rative type I endoleak in the hostile neck of 30% vs 8.7% for
avorable neck (P  .004), a higher incidence of overall
arly type I endoleak of 43% for hostile neck vs 24.6% for
avorable neck (P .0028), a higher incidence of the use of
ntraoperative proximal aortic cuff extensions in the hostile
eck of 29% vs 8.7% for a favorable neck (P .001), and an
ncreasing incidence of early intervention of 56% for hostile
eck vs 9.5% for favorable neck (P  .0001).
Neck anatomy and late clinical outcome. The rate
f freedom from late type I endoleaks at 1, 2, 3, and 4
ears were 97%, 97%, 97%, and 90% for FNA vs 89%,
9%, 89%, and 89% for HNA (P  .1224, Fig 1). One
atient who had an AneuRx device and favorable neck
natomy had a distal late type I endoleak that was treated
y an iliac extension. Overall, type I endoleak occurred
n 8% of patients with FNA and in 11% of patients with
NA (P  .9218). Late type II endoleaks were also
imilar, 11% for FNA vs 10% for HNA. One patient in the
NA group had a late type III endoleak.
The rates for late intervention at 1, 2, 3, and 4 years
ere 95%, 90%, 90%, and 90% for FNA vs 95%, 93%,
1%, and 85% for HNA (P  .6902, Fig 2). Overall, 5
atients (6%) in the FNA group underwent late interven-
ions, including coil embolization of type II endoleaks in
patients, contralateral iliac limb extensions in 2 pa-
ients, and a revision of a femoral-to-femoral bypass graft
n 1 patient. None of these patients had early endoleaks.
n contrast, 10 patients (7%) underwent late intervention
ses
Aortic cuff
P OR 95% CI P
.0984 1.77 0.81-3.87 .155
.0018a 4.94 1.89-12.88 .0011a
.909 1.45 0.46-4.61 .5297
.0014a 3.42 1.16-10.04 .0254a
.8376 0.81 0.4-1.65 .5629
.0001a 6.22 2.93-13.2 .0001a
.612 1.23 0.48-3.14 .6602
.0639 4.15 1.33-1299 .0146a
.4261 0.94 0.25-3.51 .9215
.1556 1.22 0.33-4.48 .7615
.9232 0.68 0.30-1.54 .3558
.0001a 5.95 2.66-13.29 .0001a
28 diameter.analy
leakn the HNA group, including insertion of a proximal
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Volume 54, Number 1 AbuRahma et al 19aortic cuff for late type I endoleak in 2, aortic cuff
extensions for graft migration in 2, aortic cuff extensions
to repair type III endoleak in 1, distal iliac extensions for
type I late endoleak in 2, 1 conversion to aortouniiliac
device with a femoral-to-femoral bypass graft, 1 femoral-
to-femoral bypass graft for late limb occlusion, and 1
excision of an infected graft.
Graft patency at 1, 2, and 3 years was 99%, 99%, and
99% for FNA vs 97%, 92%, and 90% for HNA (P 
.0925). At late follow-up, AAA sacs were stable or re-
gressed in 94% for FNA vs 93% for HNA (P  .8509).
The freedom from sac expansion at 1, 2, 3, and 4 years
was 99%, 93%, 93%, and 87% for FNA and 93%, 91%,
89%, and 89% for HNA (P .6084, Fig 3). Survival rates
at 1, 2, 3, and 4 years were 93% 84%, 76%, and 76% for
FNA vs 88%, 82%, 74%, and 66% for HNA (P  .2631).
One late death was caused by a ruptured AAA. This
patient had an 8.5-cm aneurysm, which was treated with
a Zenith Cook device. A late type I endoleak developed
at 6 months with an increase in aneurysmal size to 10 cm;
however, the patient refused treatment and died of a
rupture 5 months later.
Multivariate logistic regression analysis. As noted
in Table VII, reverse taper was a significant predictor for
early type I endoleak (odds ratio [OR], 5.25; 95% confi-
dence interval [CI], 2.4-11.46; P  .0001), whereas neck
length had an OR of 2.97 (95% CI, 0.94-9.41; P .0639).
Reverse taper and neck length were also significant predic-
tors for the use of proximal aortic cuffs (OR, 5.95; 95% CI,
2.66-13.29; P .0001 for reverse taper and OR, 4.15; 95%
CI, 1.33-12.99; P  .0146, respectively). Meanwhile,
none of the neck anatomy features were significant predic-
tors for late type I endoleaks or late intervention. However,
circumferential thrombus and neck angle were significant
predictors for perioperative complications (OR, 2.44; 95%
CI, 1.02-5.85; P  .0448; and OR, 3.38; 95% CI, 1.36-
Table VII. Continued
Late type I endoleak Later i
OR 95% CI P OR 95
2.25 0.73-6.94 .1584 0.64 0.14
3.19 0.82-12.46 .0957 3 0.77
NDb 0.86 0.11
2.45 0.5-12.05 .2694 2.67 0.54
0.57 0.18-1.84 .3437 0.79 0.26
0.95 0.25-3.54 .9377 2.39 0.75
2.66 0.78-9.15 .1194 0.59 0.11
3.89 0.77-19.72 .1015 1.62 0.29
NDb 0.84 0.1
1.03 0.14-7.88 .9739 2.07 0.34
0.58 0.17-1.97 .3847 0.89 0.27
0.71 0.17-2.94 .6367 2.25 0.658.45; P  .009, respectively). HISCUSSION
EVAR has been gradually replacing open repair for the
reatment of infrarenal AAAs12,13,17-21 and now accounts
or more than half of all AAA repairs nationwide. Since first
ntroduced in 1991 by Parodii,1 EVAR has been validated
n a number of large multicenter clinical trials and single-
enter experiences.17,18,20,22,23 There is no longer a dis-
ute regarding the early benefits of EVAR, such as a shorter
ospital stay, less blood loss, and lower early morbidity and
ortality. The applicability and feasibility of EVAR in
igh-risk patients has been validated in multicenter reports,
nd midterm results are sufficiently encouraging to justify
his procedure.18
As we published previously,4 the suitability of EVAR is
sually based on the manufacturer’s IFU, which require
hat certain standards be fulfilled for a better outcome. This
ncludes specific infrarenal aortic neck characteristics such
s 60° of neck angulation, a neck length of 15 mm (10
m for Medtronic, Talent device), and a neck diameter
etween 17 and 25 mm, with minimal calcification and
eck thrombus. As the indications for EVAR continue to
xpand, the number of patients with HNA continues to
row as well. More than 60% of the patients in our study
ad HNA compared with only 37% with FNA.
Aneurysm neck anatomy is the most crucial factor in
etermining whether a patient can be successfully treated
ith EVAR.4-8,10,12-14,17,24,25-27 Therefore, HNA is a real
hallenge during planning for EVAR, secondary to an
nability to form a proximal seal with subsequent type I
ndoleaks, a covering or dissecting the renal arteries, renal
rtery distal embolization, graft migration, or other com-
lications that can occur because of excessive manipulations
nd overdilation, and these remain the primary reasons for
atients to undergo open AAA repair. Some reports have
xamined the implications of certain individual features of
ention At least 1 peri-op complication
P OR 95% CI P
.5621 4.19 1.80-9.73 .0009a
7 .113 2.13 0.66-6.92 .2081
.8848 1.22 0.34-4.43 .7584
9 .2291 4.13 1.32-12.99 .0151a
.6681 2.5 1.1-5.66 .028a
.1427 1.37 0.54-3.45 .5111
.1989 3.38 1.36-8.45 .009a
.8453 1.28 0.31-5.3 .7341
.4316 1.13 0.28-1.56 .8682
4 .8714 3.54 0.84-14.91 .0855
.5869 2.44 1.02-5.85 .0448a
.5268 0.81 0.28-2.34 .702nterv
% CI
-2.93
-11.6
-6.9
-13.1
-2.38
-7.66
-3.03
-9.16
-7.21
-12.6
-2.95
-7.76NA in EVAR4-8,10,17,19,23,26; however, very few reports
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July 201120 AbuRahma et alhave examined most aspects of neck morphology as predic-
tors of early and late outcomes after EVAR.12-14
It is intuitively reasonable that better results with fewer
complications can be achieved when EVAR is performed
within a device-specific IFU. In the European Collabora-
tors on Stent-Graft Techniques for AAA and Thoracic
Aortic Aneurysm and Dissection Repair (EUROSTAR)
database,6,18,20,23 the investigators examined the effects of
aneurysm sac size, neck diameter, neck length, and neck
angulation on late outcomes. There was a higher rate
of aneurysm rupture, open conversion, and mortality in
patients with a neck diameter 26 mm after 4 years of
follow-up. Leurs et al22 found that a neck length 15 mm
was associated with significantly increased rates of early
(30 days) and late proximal type I endoleaks. Similarly,
Hobo et al20 showed that severe aneurysm neck angulation
(60°) had higher rates of early proximal type I endoleaks
and graft migration. A review by Fulton et al28 demon-
strated that patients treated outside the IFU experienced
higher rates of graft migration, device-related complica-
tions, and secondary interventions.
This study has shown that patients with HNA can be
treated adequately with EVAR with higher rates of early
type I intraoperative endoleak (22% for HNA and 9% for
FNA, P .0202) and intraoperative interventions (22% for
HNA and 8% for FNA, P .0093). However, there was no
statistically significant difference between the 2 groups
regarding late type I endoleaks or late intervention at 1, 2,
3, and 4 years. The survival and sac expansion rates were
also similar for both groups.
Some reports have outlined the difficulty of applying
EVAR to AAA patients with an HNA, while other investi-
gators have shown similar results. A study by Dillavou et al14
found no significant differences in periprocedural or late
complications in patients with HNA. Their definition of
HNA was somewhat similar to ours, but they only analyzed
the Ancure devices exclusively (with active proximal fixa-
tion) in their study. They concluded that EVAR in patients
with HNA was feasible, but special caution should be taken
with both short and angulated neck anatomy. Another
study by Fairman et al13 showed that an HNA was not
associated with an unfavorable outcome at midterm
follow-up after EVAR; however, their definition criteria for
angulated neck consisted of 45°. Also, the Talent/
Medtronic device was used exclusively in their study. They
found a similar rate of type I and II endoleaks between the
2 groups; however, there was a significantly higher inci-
dence of adverse renal events in the HNA group, which can
be secondary to more manipulations of the renal arteries.
Choke et al12 analyzed 147 EVAR patients, comprising
78 with FNA and 60 with one or more adverse neck
features (28-mm neck diameter, 60° angulation, cir-
cumferential thrombus 50%, and length of 10 mm).
They noted no significant difference between HNA and
FNA patients except that intraoperative adjunctive proce-
dures were significantly increased in the presence of severe
angulation, which was also noted in our series. Robbins et
al27 also reported that there was no association with en- toleak, stent graft migration, or sac expansion in patients
ith HNA; however, there was more device kinking in this
roup.
Multivariate logistic regression analysis of our data
evealed that reverse taper was a significant predictor for
arly type I endoleak (OR, 5.25; P  .0001), reverse taper
OR, 5.95; P  .0001), and neck length (OR, 4.15; P 
0146) were significant predictors for proximal aortic cuff
se (to seal early type I endoleaks), and circumferential
hrombus (OR, 2.44; P  .0448) and neck angle (OR,
.38; P  .009) were predictors for perioperative compli-
ations.
Our data show that placement of endografts outside
he device-specific IFU parameters is associated with higher
verall perioperative complications. We did not detect a
ifference in patient demographics or clinical characteristics
ased on IFU status, indicating that patients treated out-
ide IFU simply had anatomically more complicated aneu-
ysms than those within IFU and did not represent a group
t higher medical to account for the somewhat higher
ortality in the HNA group. Presumably, the higher rates
f early interventions and graft-related adverse events that
e observed in patients treated outside the IFU contrib-
ted to a higher rate of perioperative complications.
Our present follow-up protocol for patients with no
mmediate postoperative endoleaks on completion angio-
ram is to obtain a CT scan and color DUS imaging at 30
ays, which if normal with no endoleak and a stable sac size,
ill be followed by DUS imaging between 3 to 6 months
nd at 1 year and every year thereafter if no endoleak is
etected with a stable or regressed AAA sac. If an endoleak
s detected on color DUS imaging or there is an increase in
ac size, the patient will undergo CT scanning and manage-
ent accordingly.
Given the relatively high number of secondary inter-
entions in these patients with hostile neck features, some
uthorities may feel it is more reasonable for these patients
o undergo open repair if they are good-risk patients.
herefore, future prospective studies are warranted before
he use of EVAR in this group of patients.
The main limitation of our study is that it is retro-
pective; therefore, these results should be examined
autiously. Also, the Gore Excluder was used in 135
atients, but only 7 patients received the Talent
edtronic device, and this can have a profound effect on
etermining outcome differences between device
roups. We also had a shorter follow-up time for the
alent device because this device became commercially
vailable later than the other devices. Device selection
as based on physician preference, and this heteroge-
eous selection may carry a selection bias.
ONCLUSIONS
Patients with HNA can be treated with EVAR, but with
igher rates of early intraoperative type I endoleak and
ntervention. However, the midterm outcomes are similar
o FNA. Future prospective studies are warranted before
he use of EVAR is expanded in this group of patients.
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